David Lee Johnson

Insider Reports History

Entity
Individual
Location
C/O Global Blood Therapeutics, 171 Oyster Point Blvd, Ste. 300, San Francisco, CA
Signature
/s/ Joseph R. Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Lee Johnson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Caribou Biosciences, Inc. Director Option to purchase Common Stock 39.5K $106K $2.69 Feb 20, 2024 Direct
Vera Therapeutics, Inc. Chief Operating Officer Stock Option (right to buy) 160K Jul 1, 2024 Direct
Global Blood Therapeutics, Inc. Chief Commercial Officer Common Stock 0 $46.99 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Chief Commercial Officer Restricted Stock Units 0 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 0 Oct 5, 2022 Direct

Insider Reports Filed by David Lee Johnson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERA Vera Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 Chief Operating Officer
VERA Vera Therapeutics, Inc. Jul 1, 2024 0 $0 3 Jul 3, 2024 Chief Operating Officer
CRBU Caribou Biosciences, Inc. Feb 20, 2024 1 $0 4 Feb 22, 2024 Director
CRBU Caribou Biosciences, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 Director
GBT Global Blood Therapeutics, Inc. Oct 5, 2022 13 $0 4 Oct 6, 2022 Chief Commercial Officer
GBT Global Blood Therapeutics, Inc. Sep 1, 2022 6 -$134K 4 Sep 6, 2022 Chief Commercial Officer
GBT Global Blood Therapeutics, Inc. Aug 1, 2022 4 -$75.9K 4 Aug 3, 2022 Chief Commercial Officer
CRBU Caribou Biosciences, Inc. May 18, 2022 1 $0 4 May 18, 2022 Director
CRBU Caribou Biosciences, Inc. May 11, 2022 0 $0 3 May 12, 2022 Director
GBT Global Blood Therapeutics, Inc. Apr 1, 2022 3 -$54.3K 4 Apr 5, 2022 Chief Commercial Officer
GBT Global Blood Therapeutics, Inc. Mar 1, 2022 7 -$16.6K 4 Mar 3, 2022 Chief Commercial Officer
GBT Global Blood Therapeutics, Inc. Feb 1, 2022 4 -$75.1K 4 Feb 3, 2022 Chief Commercial Officer
GBT Global Blood Therapeutics, Inc. Oct 1, 2021 3 -$57K 4 Oct 5, 2021 Chief Commercial Officer
GBT Global Blood Therapeutics, Inc. Sep 1, 2021 4 -$20.3K 4 Sep 3, 2021 Chief Commercial Officer
GBT Global Blood Therapeutics, Inc. Aug 1, 2021 4 -$64K 4/A Sep 24, 2021 Chief Commercial Officer